During the past decade, Peking University Sixth Hospital conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 4 clinical trials were completed, i.e. on average, 22.2% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 3 clinical trials were completed. i.e. 30% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Peking University Sixth Hospital" #1 sponsor was "Peking University" with 7 trials, followed by "Peking University Sixth Hospital" with 4 trials sponsored, "Shanghai Mental Health Center" with 4 trials sponsored, "Boehringer Ingelheim" with 3 trials sponsored and "Sumitomo Pharma (Suzhou) Co., Ltd." with 3 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Peking University Sixth Hospital" #1 collaborator was "Su Zhou YiHua Biotechnology Co. LTD" with 2 trials as a collaborator, "Beijing Novartis Pharma" with 1 trials as a collaborator, "Capital Medical University" with 1 trials as a collaborator, "Dalian Seventh People's Hospital" with 1 trials as a collaborator and "First Hospital of China Medical University" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Peking University Sixth Hospital" are "Schizophrenia" (4 trials), "Major Depressive Disorder (MDD)" (3 trials), "Attention Deficit Hyperactivity Disorder" (2 trials), "Insomnia" (2 trials) and "Major Depressive Disorder" (2 trials). Many other conditions were trialed in "Peking University Sixth Hospital" in a lesser frequency.

Most popular intervention types in "Peking University Sixth Hospital" are "Drug" (18 trials), "Behavioral" (3 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Anyu Peibo" (2 trials), "Blonanserin" (2 trials), "Aripiprazole" (1 trials) and "Atomoxetine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Peking University Sixth Hospital" are 25 trials for "All" genders.

Currently, there are NaN active trials in "Peking University Sixth Hospital". 1 are not yet recruiting, 6 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Peking University Sixth Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Peking University Sixth Hospital, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 5 trials that are defined as “Not Applicable".